Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects.

Our results provided evidence that damaging variants of FGF8 and FGF10 were likely contribute to the etiology of CTD. This discovery expanded the spectrum of FGF mutations and underscored the pathogenic correlation between FGF mutations and CTD.